UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Position in Heartflow, Inc. $HTFL

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Heartflow, Inc. (NASDAQ:HTFL) by 3.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,465,650 shares of the company’s stock after buying an additional 50,822 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Heartflow were worth $43,002,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Vanguard Group Inc. purchased a new stake in shares of Heartflow in the third quarter valued at $48,871,000. Legal & General Group Plc purchased a new position in shares of Heartflow during the 3rd quarter worth about $59,000. Franklin Resources Inc. bought a new position in Heartflow during the 3rd quarter valued at about $10,829,000. UBS Group AG purchased a new stake in Heartflow in the 3rd quarter worth about $5,130,000. Finally, Sei Investments Co. bought a new stake in Heartflow in the third quarter worth about $303,000.

Insider Activity

In other Heartflow news, insider Campbell Rogers sold 9,219 shares of the firm’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $41.23, for a total transaction of $380,099.37. Following the transaction, the insider owned 86,459 shares of the company’s stock, valued at approximately $3,564,704.57. This trade represents a 9.64% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John Farquhar sold 38,900 shares of the business’s stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $35.00, for a total transaction of $1,361,500.00. Following the completion of the sale, the chief executive officer owned 457,935 shares of the company’s stock, valued at approximately $16,027,725. This represents a 7.83% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 191,271 shares of company stock worth $7,089,136. 7.70% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

HTFL has been the topic of a number of analyst reports. Piper Sandler reaffirmed an “overweight” rating and set a $45.00 target price (up from $38.00) on shares of Heartflow in a research note on Friday, August 14th. Stifel Nicolaus boosted their price objective on Heartflow from $40.00 to $45.00 and gave the company a “buy” rating in a report on Friday, August 14th. Canaccord Genuity Group upped their price objective on Heartflow from $37.00 to $45.00 and gave the company a “buy” rating in a research report on Friday, August 14th. Robert W. Baird set a $45.00 target price on Heartflow in a research note on Friday, August 14th. Finally, Benchmark reiterated a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Heartflow presently has an average rating of “Moderate Buy” and an average price target of $43.43.

Heartflow Stock Performance

Heartflow stock opened at $49.71 on Friday. The company has a market capitalization of $4.32 billion and a PE ratio of -27.16. The company has a 50 day moving average price of $33.50 and a 200-day moving average price of $29.79. Heartflow, Inc. has a fifty-two week low of $20.13 and a fifty-two week high of $51.78.

Heartflow (NASDAQ:HTFL) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.22) by $0.15. The company had revenue of $64.08 million for the quarter. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The business’s quarterly revenue was up 47.7% on a year-over-year basis. On average, analysts forecast that Heartflow, Inc. will post -0.75 earnings per share for the current year.

Heartflow Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.